Annual Total Long Term Liabilities
$30.97 B
-$1.06 B-3.31%
December 1, 2024
Summary
- As of February 25, 2025, GSK annual total long term liabilities is $30.97 billion, with the most recent change of -$1.06 billion (-3.31%) on December 1, 2024.
- During the last 3 years, GSK annual total long term liabilities has fallen by -$15.04 billion (-32.69%).
- GSK annual total long term liabilities is now -39.36% below its all-time high of $51.07 billion, reached on December 31, 2020.
Performance
GSK Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$30.97 B
+$6.05 M+0.02%
December 1, 2024
Summary
- As of February 25, 2025, GSK quarterly total long term liabilities is $30.97 billion, with the most recent change of +$6.05 million (+0.02%) on December 1, 2024.
- Over the past year, GSK quarterly long term liabilities has stayed the same.
- GSK quarterly long term liabilities is now -44.89% below its all-time high of $56.19 billion, reached on March 31, 2022.
Performance
GSK Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
GSK Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.3% | 0.0% |
| 3 y3 years | -32.7% | 0.0% |
| 5 y5 years | -36.6% | 0.0% |
GSK Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -32.7% | at low | -44.9% | +2.2% |
| 5 y | 5-year | -39.4% | at low | -44.9% | +2.2% |
| alltime | all time | -39.4% | >+9999.0% | -44.9% | >+9999.0% |
GSK Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $30.97 B(-3.3%) | $30.97 B(+0.0%) |
| Sep 2024 | - | $30.96 B(+2.2%) |
| Jun 2024 | - | $30.29 B(-5.7%) |
| Mar 2024 | - | $32.11 B(+0.3%) |
| Dec 2023 | $32.03 B(-2.8%) | $32.03 B(+1.5%) |
| Sep 2023 | - | $31.54 B(-0.7%) |
| Jun 2023 | - | $31.78 B(-3.5%) |
| Mar 2023 | - | $32.93 B(-0.1%) |
| Dec 2022 | $32.97 B(-28.4%) | $32.97 B(-3.7%) |
| Sep 2022 | - | $34.22 B(-1.2%) |
| Jun 2022 | - | $34.65 B(-38.3%) |
| Mar 2022 | - | $56.19 B(+22.1%) |
| Dec 2021 | $46.01 B(-9.9%) | $46.01 B(-0.7%) |
| Sep 2021 | - | $46.36 B(-1.6%) |
| Jun 2021 | - | $47.12 B(-6.8%) |
| Mar 2021 | - | $50.57 B(-1.0%) |
| Dec 2020 | $51.07 B(+4.5%) | $51.07 B(+4.1%) |
| Sep 2020 | - | $49.04 B(-1.8%) |
| Jun 2020 | - | $49.95 B(+3.7%) |
| Mar 2020 | - | $48.18 B(-1.4%) |
| Dec 2019 | $48.89 B(+20.8%) | $48.89 B(+0.3%) |
| Sep 2019 | - | $48.76 B(+10.3%) |
| Jun 2019 | - | $44.21 B(-1.8%) |
| Mar 2019 | - | $45.04 B(+11.3%) |
| Dec 2018 | $40.48 B(+13.8%) | $40.48 B(-14.8%) |
| Sep 2018 | - | $47.54 B(-0.1%) |
| Jun 2018 | - | $47.61 B(+32.5%) |
| Mar 2018 | - | $35.94 B(+1.0%) |
| Dec 2017 | $35.57 B(-17.5%) | $35.57 B(-0.1%) |
| Sep 2017 | - | $35.61 B(+9.4%) |
| Jun 2017 | - | $32.55 B(-25.2%) |
| Mar 2017 | - | $43.53 B(+0.9%) |
| Dec 2016 | $43.14 B(-6.5%) | $43.14 B(-9.2%) |
| Sep 2016 | - | $47.51 B(+0.0%) |
| Jun 2016 | - | $47.51 B(-2.8%) |
| Mar 2016 | - | $48.89 B(+5.9%) |
| Dec 2015 | $46.15 B(+32.3%) | $46.15 B(-1.9%) |
| Sep 2015 | - | $47.04 B(+0.5%) |
| Jun 2015 | - | $46.81 B(+2.6%) |
| Mar 2015 | - | $45.61 B(+30.7%) |
| Dec 2014 | $34.90 B(+2.7%) | $34.90 B(+11.4%) |
| Sep 2014 | - | $31.32 B(-7.0%) |
| Jun 2014 | - | $33.66 B(-1.9%) |
| Mar 2014 | - | $34.30 B(+1.0%) |
| Dec 2013 | $33.96 B(+0.4%) | $33.96 B(-2.2%) |
| Sep 2013 | - | $34.72 B(+2.0%) |
| Jun 2013 | - | $34.03 B(-3.7%) |
| Mar 2013 | - | $35.36 B(+4.5%) |
| Dec 2012 | $33.82 B(+27.3%) | $33.82 B(+7.1%) |
| Sep 2012 | - | $31.58 B(+5.7%) |
| Jun 2012 | - | $29.88 B(+12.2%) |
| Mar 2012 | - | $26.63 B(+0.2%) |
| Dec 2011 | $26.57 B(-12.6%) | $26.57 B(-15.1%) |
| Sep 2011 | - | $31.30 B(+2.4%) |
| Jun 2011 | - | $30.57 B(-2.8%) |
| Mar 2011 | - | $31.47 B(+3.5%) |
| Dec 2010 | $30.39 B(-6.0%) | $30.39 B(-7.4%) |
| Sep 2010 | - | $32.84 B(+2.2%) |
| Jun 2010 | - | $32.14 B(+0.9%) |
| Mar 2010 | - | $31.84 B(-1.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2009 | $32.35 B(+4.9%) | $32.35 B(-2.3%) |
| Sep 2009 | - | $33.11 B(+6.4%) |
| Jun 2009 | - | $31.11 B(+3.3%) |
| Mar 2009 | - | $30.11 B(-2.4%) |
| Dec 2008 | $30.84 B(+44.3%) | $30.84 B(+0.3%) |
| Sep 2008 | - | $30.76 B(-6.7%) |
| Jun 2008 | - | $32.98 B(+40.1%) |
| Mar 2008 | - | $23.54 B(+10.2%) |
| Dec 2007 | $21.37 B(+26.3%) | $21.37 B(+23.3%) |
| Sep 2007 | - | $17.34 B(+0.6%) |
| Jun 2007 | - | $17.23 B(-0.2%) |
| Mar 2007 | - | $17.26 B(+2.0%) |
| Dec 2006 | $16.92 B(-2.8%) | $16.92 B(-1.3%) |
| Sep 2006 | - | $17.14 B(+0.7%) |
| Jun 2006 | - | $17.01 B(+2.3%) |
| Mar 2006 | - | $16.64 B(-4.4%) |
| Dec 2005 | $17.39 B(+12.1%) | $17.39 B(-0.1%) |
| Sep 2005 | - | $17.41 B(+0.1%) |
| Jun 2005 | - | $17.39 B(+13.1%) |
| Mar 2005 | - | $15.37 B(-1.0%) |
| Dec 2004 | $15.52 B(+25.7%) | $15.52 B(+24.7%) |
| Sep 2004 | - | $12.45 B(+19.3%) |
| Jun 2004 | - | $10.43 B(-24.7%) |
| Mar 2004 | - | $13.86 B(+12.2%) |
| Dec 2003 | $12.35 B(+24.9%) | $12.35 B(+3.8%) |
| Sep 2003 | - | $11.90 B(+0.8%) |
| Jun 2003 | - | $11.81 B(+20.7%) |
| Mar 2003 | - | $9.78 B(-1.0%) |
| Dec 2002 | $9.88 B(+65.7%) | $9.88 B(+14.9%) |
| Sep 2002 | - | $8.60 B(+10.3%) |
| Jun 2002 | - | $7.80 B(+7.8%) |
| Mar 2002 | - | $7.24 B(+21.3%) |
| Dec 2001 | $5.96 B(+12.6%) | $5.96 B(+0.6%) |
| Sep 2001 | - | $5.93 B(+3.5%) |
| Jun 2001 | - | $5.73 B(-4.9%) |
| Mar 2001 | - | $6.03 B(+13.8%) |
| Dec 2000 | $5.29 B(+66.2%) | $5.29 B(-5.7%) |
| Sep 2000 | - | $5.61 B(-4.0%) |
| Jun 2000 | - | $5.85 B(-3.6%) |
| Mar 2000 | - | $6.07 B(+90.5%) |
| Dec 1999 | $3.18 B(-20.9%) | $3.18 B(-11.5%) |
| Jun 1999 | - | $3.60 B(-10.6%) |
| Dec 1998 | $4.02 B(-8.7%) | $4.02 B(-9.4%) |
| Jun 1998 | - | $4.44 B(+0.8%) |
| Dec 1997 | $4.41 B(-10.4%) | $4.41 B(-10.4%) |
| Dec 1996 | $4.92 B(+11.1%) | $4.92 B(-29.3%) |
| Dec 1995 | $4.43 B(-36.3%) | - |
| Jun 1995 | - | $6.95 B(+642.4%) |
| Jun 1995 | $6.95 B(+642.4%) | - |
| Jun 1994 | $936.62 M(+3.3%) | $936.62 M(+3.3%) |
| Jun 1993 | $906.73 M(+0.5%) | $906.73 M(+0.5%) |
| Jun 1992 | $902.50 M(+27.9%) | $902.50 M(+27.9%) |
| Jun 1991 | $705.66 M(+44.1%) | $705.66 M(+44.1%) |
| Jun 1990 | $489.78 M(+7.9%) | $489.78 M(+7.9%) |
| Jun 1989 | $454.09 M(+36.3%) | $454.09 M(+36.3%) |
| Jun 1988 | $333.23 M(+13.1%) | $333.23 M(+13.1%) |
| Jun 1987 | $294.62 M(+33.7%) | $294.62 M(+33.7%) |
| Jun 1986 | $220.39 M(+58.4%) | $220.39 M |
| Jun 1985 | $139.14 M(+33.2%) | - |
| Jun 1984 | $104.45 M | - |
FAQ
- What is GSK annual total long term liabilities?
- What is the all time high annual total long term liabilities for GSK?
- What is GSK annual total long term liabilities year-on-year change?
- What is GSK quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for GSK?
- What is GSK quarterly long term liabilities year-on-year change?
What is GSK annual total long term liabilities?
The current annual total long term liabilities of GSK is $30.97 B
What is the all time high annual total long term liabilities for GSK?
GSK all-time high annual total long term liabilities is $51.07 B
What is GSK annual total long term liabilities year-on-year change?
Over the past year, GSK annual total long term liabilities has changed by -$1.06 B (-3.31%)
What is GSK quarterly total long term liabilities?
The current quarterly long term liabilities of GSK is $30.97 B
What is the all time high quarterly long term liabilities for GSK?
GSK all-time high quarterly total long term liabilities is $56.19 B
What is GSK quarterly long term liabilities year-on-year change?
Over the past year, GSK quarterly total long term liabilities has changed by $0.00 (0.00%)